Table 2 Change from baseline (expressed as a ratio) in 24-h weighted mean SC at week 6
Variables | Placebo group | FF 50 QD group |
|---|---|---|
SC population | ||
N | 51 | 53 |
n | 50 | 52 |
LS geometric mean (nmol/L) | 173.25 | 160.65 |
LS ratio to baseline | 1.05 | 0.97 |
FF 50 QD/placebo ratio | – | 0.93 |
95% CI | – | 0.8096, 1.0620 |
ITT population | ||
N | 55 | 56 |
n | 51 | 53 |
LS geometric mean (nmol/L) | 174.08 | 159.98 |
LS ratio to baseline | 1.06 | 0.97 |
FF 50 QD/placebo ratio | – | 0.92 |
95% CI | – | 0.8040, 1.0505 |